BioCardia, Inc. is a pioneering biotechnology company based in Sunnyvale, CA that is dedicated to revolutionizing the treatment of cardiovascular and pulmonary diseases. With a focus on personalized medicine, BioCardia develops cellular and cell-derived therapeutics to address unmet medical needs, particularly in the field of heart failure. By combining patient screening, personalized stem cell therapy, and innovative delivery systems, BioCardia aims to improve the lives of patients and increase the success rate of treatment.
With a comprehensive approach to heart failure, BioCardia is at the forefront of developing cutting-edge therapies. Their product portfolio includes the Helix Biotherapeutic Delivery System and AVANCE Steerable Introducers, which enable efficient and precise delivery of their cell-based therapies. Through ongoing clinical trials and scientific publications, BioCardia continues to advance the field of cardiac cell therapy, bringing hope to those suffering from heart disease.
Generated from the website